Literature DB >> 29523926

Parametric mapping using spectral analysis for 11C-PBR28 PET reveals neuroinflammation in mild cognitive impairment subjects.

Zhen Fan1, Melanie Dani1, Grazia D Femminella1, Melanie Wood1, Valeria Calsolaro1, Mattia Veronese2, Federico Turkheimer2, Steve Gentleman1, David J Brooks1,3, Rainer Hinz4, Paul Edison5.   

Abstract

PURPOSE: Neuroinflammation and microglial activation play an important role in amnestic mild cognitive impairment (MCI) and Alzheimer's disease. In this study, we investigated the spatial distribution of neuroinflammation in MCI subjects, using spectral analysis (SA) to generate parametric maps and quantify 11C-PBR28 PET, and compared these with compartmental and other kinetic models of quantification.
METHODS: Thirteen MCI and nine healthy controls were enrolled in this study. Subjects underwent 11C-PBR28 PET scans with arterial cannulation. Spectral analysis with an arterial plasma input function was used to generate 11C-PBR28 parametric maps. These maps were then compared with regional 11C-PBR28 VT (volume of distribution) using a two-tissue compartment model and Logan graphic analysis. Amyloid load was also assessed with 18F-Flutemetamol PET.
RESULTS: With SA, three component peaks were identified in addition to blood volume. The 11C-PBR28 impulse response function (IRF) at 90 min produced the lowest coefficient of variation. Single-subject analysis using this IRF demonstrated microglial activation in five out of seven amyloid-positive MCI subjects. IRF parametric maps of 11C-PBR28 uptake revealed a group-wise significant increase in neuroinflammation in amyloid-positive MCI subjects versus HC in multiple cortical association areas, and particularly in the temporal lobe. Interestingly, compartmental analysis detected group-wise increase in 11C-PBR28 binding in the thalamus of amyloid-positive MCI subjects, while Logan parametric maps did not perform well.
CONCLUSIONS: This study demonstrates for the first time that spectral analysis can be used to generate parametric maps of 11C-PBR28 uptake, and is able to detect microglial activation in amyloid-positive MCI subjects. IRF parametric maps of 11C-PBR28 uptake allow voxel-wise single-subject analysis and could be used to evaluate microglial activation in individual subjects.

Entities:  

Keywords:  11C–PBR28; Compartmental modelling; Logan graphic analysis; MCI; PET; Spectral analysis

Mesh:

Substances:

Year:  2018        PMID: 29523926      PMCID: PMC5993844          DOI: 10.1007/s00259-018-3984-5

Source DB:  PubMed          Journal:  Eur J Nucl Med Mol Imaging        ISSN: 1619-7070            Impact factor:   9.236


  37 in total

1.  Can Studies of Neuroinflammation in a TSPO Genetic Subgroup (HAB or MAB) Be Applied to the Entire AD Cohort?

Authors:  Zhen Fan; Denise Harold; Giuseppe Pasqualetti; Julie Williams; David J Brooks; Paul Edison
Journal:  J Nucl Med       Date:  2015-04-03       Impact factor: 10.057

2.  Spectral analysis of dynamic PET studies.

Authors:  V J Cunningham; T Jones
Journal:  J Cereb Blood Flow Metab       Date:  1993-01       Impact factor: 6.200

3.  Microglial activation in Alzheimer's disease: an (R)-[¹¹C]PK11195 positron emission tomography study.

Authors:  Alie Schuitemaker; Marc A Kropholler; Ronald Boellaard; Wiesje M van der Flier; Reina W Kloet; Thalia F van der Doef; Dirk L Knol; Albert D Windhorst; Gert Luurtsema; Frederik Barkhof; Cees Jonker; Adriaan A Lammertsma; Philip Scheltens; Bart N M van Berckel
Journal:  Neurobiol Aging       Date:  2012-07-26       Impact factor: 4.673

4.  Detection of microglial activation in an acute model of neuroinflammation using PET and radiotracers 11C-(R)-PK11195 and 18F-GE-180.

Authors:  Alex M Dickens; Susanne Vainio; Päivi Marjamäki; Jarkko Johansson; Paula Lehtiniemi; Johanna Rokka; Juha Rinne; Olof Solin; Merja Haaparanta-Solin; Paul A Jones; William Trigg; Daniel C Anthony; Laura Airas
Journal:  J Nucl Med       Date:  2014-02-10       Impact factor: 10.057

5.  Depiction of microglial activation in aging and dementia: Positron emission tomography with [11C]DPA713 versus [11C]( R)PK11195.

Authors:  Masamichi Yokokura; Tatsuhiro Terada; Tomoyasu Bunai; Kyoko Nakaizumi; Kiyokazu Takebayashi; Yasuhide Iwata; Etsuji Yoshikawa; Masami Futatsubashi; Katsuaki Suzuki; Norio Mori; Yasuomi Ouchi
Journal:  J Cereb Blood Flow Metab       Date:  2016-07-21       Impact factor: 6.200

Review 6.  Neuroinflammation in Alzheimer's disease.

Authors:  Michael T Heneka; Monica J Carson; Joseph El Khoury; Gary E Landreth; Frederic Brosseron; Douglas L Feinstein; Andreas H Jacobs; Tony Wyss-Coray; Javier Vitorica; Richard M Ransohoff; Karl Herrup; Sally A Frautschy; Bente Finsen; Guy C Brown; Alexei Verkhratsky; Koji Yamanaka; Jari Koistinaho; Eicke Latz; Annett Halle; Gabor C Petzold; Terrence Town; Dave Morgan; Mari L Shinohara; V Hugh Perry; Clive Holmes; Nicolas G Bazan; David J Brooks; Stéphane Hunot; Bertrand Joseph; Nikolaus Deigendesch; Olga Garaschuk; Erik Boddeke; Charles A Dinarello; John C Breitner; Greg M Cole; Douglas T Golenbock; Markus P Kummer
Journal:  Lancet Neurol       Date:  2015-04       Impact factor: 44.182

7.  SAKE: a new quantification tool for positron emission tomography studies.

Authors:  Mattia Veronese; Gaia Rizzo; Federico E Turkheimer; Alessandra Bertoldo
Journal:  Comput Methods Programs Biomed       Date:  2013-04-20       Impact factor: 5.428

8.  Influence of microglial activation on neuronal function in Alzheimer's and Parkinson's disease dementia.

Authors:  Zhen Fan; Yahyah Aman; Imtiaz Ahmed; Gaël Chetelat; Brigitte Landeau; K Ray Chaudhuri; David J Brooks; Paul Edison
Journal:  Alzheimers Dement       Date:  2014-09-16       Impact factor: 21.566

9.  Identifying improved TSPO PET imaging probes through biomathematics: the impact of multiple TSPO binding sites in vivo.

Authors:  Qi Guo; David R Owen; Eugenii A Rabiner; Federico E Turkheimer; Roger N Gunn
Journal:  Neuroimage       Date:  2012-01-10       Impact factor: 6.556

10.  The use of spectral analysis to determine regional cerebral glucose utilization with positron emission tomography and [18F]fluorodeoxyglucose: theory, implementation, and optimization procedures.

Authors:  F Turkheimer; R M Moresco; G Lucignani; L Sokoloff; F Fazio; K Schmidt
Journal:  J Cereb Blood Flow Metab       Date:  1994-05       Impact factor: 6.200

View more
  10 in total

1.  Assessment of simplified methods for quantification of [18F]-DPA-714 using 3D whole-brain TSPO immunohistochemistry in a non-human primate.

Authors:  Nadja Van Camp; Yaël Balbastre; Anne-Sophie Herard; Sonia Lavisse; Clovis Tauber; Catriona Wimberley; Martine Guillermier; Aurélie Berniard; Pauline Gipchtein; Caroline Jan; Romina Aron Badin; Thierry Delzescaux; Philippe Hantraye; Gilles Bonvento
Journal:  J Cereb Blood Flow Metab       Date:  2019-06-25       Impact factor: 6.200

Review 2.  Novel Tracers and Radionuclides in PET Imaging.

Authors:  Christian Mason; Grayson R Gimblet; Suzanne E Lapi; Jason S Lewis
Journal:  Radiol Clin North Am       Date:  2021-09       Impact factor: 1.947

Review 3.  Pharmacological considerations for treating neuroinflammation with curcumin in Alzheimer's disease.

Authors:  Xian Zhou; Madhuri Venigalla; Ritesh Raju; Gerald Münch
Journal:  J Neural Transm (Vienna)       Date:  2022-03-16       Impact factor: 3.850

4.  Association of Early β-Amyloid Accumulation and Neuroinflammation Measured With [11C]PBR28 in Elderly Individuals Without Dementia.

Authors:  Sini Toppala; Laura L Ekblad; Jouni Tuisku; Semi Helin; Jarkko J Johansson; Hanna Laine; Eliisa Löyttyniemi; Päivi Marjamäki; Kaj Blennow; Henrik Zetterberg; Antti Jula; Matti Viitanen; Juha O Rinne
Journal:  Neurology       Date:  2021-01-29       Impact factor: 9.910

Review 5.  Novel brain PET imaging agents: Strategies for imaging neuroinflammation in Alzheimer's disease and mild cognitive impairment.

Authors:  Jie Huang
Journal:  Front Immunol       Date:  2022-09-23       Impact factor: 8.786

6.  Parametric Mapping for TSPO PET Imaging with Spectral Analysis Impulsive Response Function.

Authors:  Mattia Veronese; Marcello Tuosto; Tiago Reis Marques; Oliver Howes; Belen Pascual; Meixiang Yu; Joseph C Masdeu; Federico Turkheimer; Alessandra Bertoldo; Paolo Zanotti-Fregonara
Journal:  Mol Imaging Biol       Date:  2021-01-21       Impact factor: 3.488

7.  Comparison of [11C]-PBR28 Binding Between Persons Living With HIV and HIV-Uninfected Individuals.

Authors:  Anna H Boerwinkle; Jeremy F Strain; Tricia Burdo; John Doyle; Jon Christensen; Yi Su; Julie K Wisch; Sarah A Cooley; Florin Vaida; Mandy D Smith; Hussain Jafri; Robert H Paul; Tammie L S Benzinger; Beau M Ances
Journal:  J Acquir Immune Defic Syndr       Date:  2020-10-01       Impact factor: 3.771

8.  Microglial activation in early Alzheimer trajectory is associated with higher gray matter volume.

Authors:  Grazia Daniela Femminella; Melanie Dani; Melanie Wood; Zhen Fan; Valeria Calsolaro; Rebecca Atkinson; Trudi Edginton; Rainer Hinz; David J Brooks; Paul Edison
Journal:  Neurology       Date:  2019-02-22       Impact factor: 9.910

Review 9.  Applications of amyloid, tau, and neuroinflammation PET imaging to Alzheimer's disease and mild cognitive impairment.

Authors:  Avinash Chandra; Polytimi-Eleni Valkimadi; Gennaro Pagano; Oliver Cousins; George Dervenoulas; Marios Politis
Journal:  Hum Brain Mapp       Date:  2019-09-14       Impact factor: 5.038

10.  PET imaging shows no changes in TSPO brain density after IFN-α immune challenge in healthy human volunteers.

Authors:  M A Nettis; M Veronese; N Nikkheslat; N Mariani; G Lombardo; L Sforzini; D Enache; N A Harrison; F E Turkheimer; V Mondelli; C M Pariante
Journal:  Transl Psychiatry       Date:  2020-03-09       Impact factor: 6.222

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.